GLPBio

LIM Kinase (LIMK)

Read More about this category

LIM kinases (LIMKs) are important cell cytoskeleton regulators that play a prominent role in cancer manifestation and neuronal diseases. The LIMK family consists of two homologues, LIMK1 and LIMK2, which differ from one another in expression profile, intercellular localization, and function. The main substrate of LIMK is cofilin, a member of the actin-depolymerizing factor (ADF) protein family. When phosphorylated by LIMK, cofilin is inactive. LIMKs play a contributory role in several neurodevelopmental disorders and in cancer growth and metastasis.

LIM domain kinases (LIMK1 and 2) are substrate for Cdc42/Rac-PAK, and modulate actin dynamics by phosphorylating cofilin at serine-3. This modification inactivates cofilin’s actin severing and depolymerizing activity. LIMKs also translocate into the nucleus and regulate cell cycle progression. LIMKs are potential therapeutic targets for NF2 and other merlin-deficient tumors.

Products Related to LIM Kinase (LIMK)(12)

  • GC15511 structure
    GC15511LIMKi 3
    CAS: 1338247-35-0
    Purity: >99.00%

    LIMKi 3 (LIMKi 3) is a potent LIMK inhibitor with IC50s of 7 nM and 8 nM for LIMK1 and LIMK2, respectively.

  • GC16355 structure
    GC16355T 5601640
    CAS: 924473-59-6
    Purity: >98.50%

    T 5601640 is a selective inhibitor of LIMK2; inhibits the growth of Panc-1 cells with an IC50 of 35.2 μM.

  • GC19076 structure
    GC19076BMS-3
    CAS: 1338247-30-5
    Purity: >99.00%

    BMS-3 is a potent LIMK inhibitor with IC50s of 5 nM and 6 nM for LIMK1 and LIMK2, respectively.

  • GC38860 structure
    GC38860TH-257
    CAS: 2244678-29-1
    Purity: >98.50%

    An inhibitor of LIMK1 and LIMK2

  • GC44094 structure
    GC44094LX7101 (hydrochloride)
    CAS: 2319882-48-7
    Purity: >98.00%

    LX7101 is a potent inhibitor of LIM kinase (LIMK) 1 and 2 and Rho-associated kinase 1 (ROCK-1) and ROCK-2 with IC50 values of 32, 4.3, 69, and 32 nM, respectively.

  • GC50219 structure
    GC50219SR 7826
    CAS: 1219728-20-7
    Purity: >98%

    Potent and selective LIMK inhibitor; antitumor

  • GC50404 structure
    GC50404CRT 0105950
    CAS: 1661845-86-8
    Purity: >98%

    Potent LIMK1/2 inhibitor

  • GC62675 structure
    GC62675SM1-71
    CAS: 2088179-99-9
    Purity: >98%

    SM1-71 (compound 5) is a potent TAK1 inhibitor, with a Ki of 160 nM, it also can covalently inhibit MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2. SM1-71 can inhibit proliferation of multiple cancer cell lines.

  • GC65207 structure
    GC65207R-10015
    CAS: 2097938-51-5
    Purity: >99.00%

    R-10015, a broad-spectrum antiviral compound for HIV infection, acts as a potent and selective inhibitor of LIM domain kinase (LIMK) and binds to the ATP-binding pocket, with an IC50 of 38 nM for human LIMK1.

  • GC68913 structure
    GC68913Curcolonol
    CAS: 217817-09-9
    Purity: >98%

    Curcolonol is a furanoid sesquiterpene that can be isolated from several herbs. It has inhibitory activity against LIM kinase 1 and can be used in breast cancer research.

  • GC71011 structure
    GC71011DB0614
    CAS: 2769753-47-9
    Purity: >98.00%

    DB0614 (Example 21) is a bifunctional compound targeted protein degradation of kinases.

  • GC73353 structure
    GC73353TH470
    CAS: 2834739-51-2
    Purity: >99.00%

    TH470 is a highly selective LIMK1/2 (LIM kinase1/2) inhibitor (LIMK1 IC50=9.8 nM; LIMK2 IC50=13 nM), and can be used in orphan disease research.